Drugs / Cosyntropin

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) CORTROSYN — 1970-04-22 fda.gov ↗

Trials 10

196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 03 trials
Phase 0 NCT04546126 Nov 2021 → Dec 2026 expected hypertensive disorder Benjamin Viglianti Recruiting No outcome recorded
Phase 0 NCT04037605 Feb 2020 → Jul 2022 overdue — Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Active not recruiting No outcome recorded
Phase 0 NCT03709381 Oct 2017 → Oct 2018 adrenocortical insufficiency, osteoporosis Nationwide Children's Hospital Completed No outcome recorded
Phase 12 trials
Phase 1 NCT03142893 May 2017 → Oct 2020 overdue — Peter y. Liu Active not recruiting No outcome recorded
Phase 1 NCT01673087 Oct 2012 → Aug 2017 — University of Michigan Completed No outcome recorded
Phase 31 trial
Phase 3 NCT03347526 Apr 2018 → Jun 2021 infantile spasms University of Colorado, Denver Suspended No outcome recorded Stop: Enrollment
Phase 42 trials
Phase 4 NCT03752190 Jul 2019 → Sep 2020 adrenocortical insufficiency Johns Hopkins University Withdrawn No outcome recorded
Phase 4 NCT02394457 Aug 2010 → Apr 2014 headache disorder United States Naval Medical Center, San Diego Completed No outcome recorded
Phase not applicable2 trials
— NCT01764711 Jan 2013 → Dec 2020 postural orthostatic tachycardia syndrome Vanderbilt University Completed No outcome recorded
— NCT01421797 Oct 2006 → Aug 2024 obesity disorder, polycystic ovary syndrome University of Virginia Unknown No outcome recorded
Comparator or background therapy4 trials
Phase 0 NCT01422733 Background Jun → Jul 2018 obesity disorder, polycystic ovary syndrome University of Virginia Withdrawn No outcome recorded
Phase 1 NCT01839812 Background Mar 2009 → Jun 2013 adrenal cortex disorder Mayo Clinic Completed No outcome recorded
Phase 3 NCT03368066 Background Jan 2018 → Mar 2019 LCAT deficiency, adrenocortical insufficiency, anemia, nonspherocytic hemolytic, cirrhosis of liver University of Virginia Completed No outcome recorded
— NCT02339506 Comparator Apr 2015 → Oct 2016 baroreflex failure Brigham and Women's Hospital Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 14 sources stand behind the page.

FieldValueCited text
Known as Cosyntropin ClinicalTrials.gov intervention name — accepted as the source's own label NCT03142893 ↗
11

NCT03709381 ↗

NCT01422733 ↗

NCT04037605 ↗

NCT01839812 ↗

NCT01764711 ↗

NCT02339506 ↗

NCT02394457 ↗

NCT03368066 ↗

NCT03752190 ↗

NCT04546126 ↗

Show 1 more source

Known as ACTH “Cosyntropin (synthetic ACTH) stimulation test” NCT03752190 ↗
Known as Cortrosyn ClinicalTrials.gov intervention name — accepted as the source's own label NCT01673087 ↗
1

NCT01421797 ↗

Route Intravenous “Cortrosyn given single IV bolus 0f 0.25 mg” NCT01421797 ↗